These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7022175)

  • 21. Mutagenic activation of 2-acetylaminofluorene by guinea-pig liver homogenates: essential involvement of cytochrome P-450 mixed-function oxidases.
    Takeishi K; Okuno-Kaneda S; Seno T
    Mutat Res; 1979 Oct; 62(3):425-37. PubMed ID: 574615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of a method for testing azo dyes for mutagenic activity in Salmonella typhimurium in the presence of flavin mononucleotide and hamster liver S9.
    Prival MJ; Mitchell VD
    Mutat Res; 1982 Apr; 97(2):103-16. PubMed ID: 7043259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effect of diethylstilbestrol on the mutagenicity of 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene in the Salmonella assay system.
    Allaben WT; Louie SC; Lazear EJ
    Cancer Lett; 1979 Jul; 7(2-3):109-14. PubMed ID: 476604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species differences in the cytotoxic and genotoxic effects of 2-acetylaminofluorene and its primary metabolites 2-aminofluorene and N-OH-2-acetylaminofluorene.
    Holme JA; Søderlund EJ
    Carcinogenesis; 1985 Mar; 6(3):421-5. PubMed ID: 3978756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenicity and DNA damage induced by arylamines in the Salmonella/hepatocyte system.
    Staiano N; Erickson LC; Smith CL; Marsden E; Thorgeirsson SS
    Carcinogenesis; 1983; 4(2):161-7. PubMed ID: 6337737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two sites of azo reduction in the monooxygenase system.
    Peterson FJ; Holtzman JL; Crankshaw D; Mason RP
    Mol Pharmacol; 1988 Oct; 34(4):597-603. PubMed ID: 2845254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
    Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
    Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differing activation pathways for 2-acetylaminofluorene to a mutagen in vitro.
    McGregor DB; McConville M; Menzies C; Prentice RD
    Mutat Res; 1982; 102(1):39-50. PubMed ID: 6750372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical models for cytochrome P450 as a biomimetic metabolic activation system in mutation assays.
    Inami K; Mochizuki M
    Mutat Res; 2002 Aug; 519(1-2):133-40. PubMed ID: 12160898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of 2-aminofluorene in the mutagenic activation of 2-acetylaminofluorene.
    Robertson IG
    Mutat Res; 1986 Nov; 175(3):153-7. PubMed ID: 3534560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells.
    Glowinski IB; Sanderson ND; Hayashi S; Thorgeirsson SS
    Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutagenic activation of aromatic amines by a human hepatoma cell (Hep G2) supernatant tested by means of Salmonella typhimurium strains with different acetyltransferase activities.
    Duverger-van Bogaert M; Dierickx PJ; Crutzen MC
    Mutat Res; 1995 Dec; 335(3):219-27. PubMed ID: 8524336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of rat urine extracted on XAD-2 resin and assayed in a microsuspension-modified Ames test as an in vivo indicator of genotoxic exposure.
    Doolittle DJ; Lee DA; Rahn CA
    Mutat Res; 1988 Oct; 206(2):141-8. PubMed ID: 3050496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deacetylation to 2-aminofluorene as a major initial reaction in the microsomal metabolism of 2-acetylaminofluorene to mutagenic products in preparations from rabbit lung and liver.
    Aune T; Vanderslice RR; Croft JE; Dybing E; Bend JR; Philpot RM
    Cancer Res; 1985 Nov; 45(11 Pt 2):5859-66. PubMed ID: 4053056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the relationship of metabolic activation system concentrations and chemical dose concentrations for the Salmonella spiral and plate assays.
    Claxton LD; Houk VS; Allison JC; Creason J
    Mutat Res; 1991 Oct; 253(2):127-36. PubMed ID: 1922139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of S9 activation by S105 cytosolic fraction.
    Forster R; Green MH; Priestley A
    Carcinogenesis; 1981; 2(11):1081-5. PubMed ID: 7032740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mutagenicity testing of some azo dyes used as food additives].
    Izbirak A; Sümer S; Diril N
    Mikrobiyol Bul; 1990 Jan; 24(1):48-56. PubMed ID: 2283964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic activation of selected aromatic amines and polycyclic hydrocarbons by isolated subcellular fractions of Drosophila melanogaster.
    Klapwijk PM; Vogel EW; Zijlstra JA
    Mutat Res; 1984 Feb; 125(2):229-41. PubMed ID: 6422283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the mutagenicity of azo dyes in Salmonella typhimurium: a study of structure-activity relationships.
    Shahin MM
    Mutagenesis; 1989 Mar; 4(2):115-25. PubMed ID: 2659922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of S9 mix on the expression of mutants in the L-arabinose resistance test of Salmonella typhimurium.
    Roldán-Arjona T; Ruiz-Rubio M; Pueyo C
    Mutat Res; 1990 Apr; 243(4):303-8. PubMed ID: 2183041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.